Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Annals of Neurology|April 1, 2018
Stem cell modeling of mitochondrial parkinsonism reveals key functions of OPA1Mindaugas Jonikas, Martin Madill, Alexandre Mathy, et al.
Cancer Research|May 20, 2016
Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor GrowthAlan McIntyre, Alzbeta Hulikova, Ioanna Ledaki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 17, 2011
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiationLudwig Dubois, Sarah Peeters, Natasja G Lieuwes, et al.
Cancer & Metabolism|July 11, 2020
Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cellsMasahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2012
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapyAlan McIntyre, Shalini Patiar, Simon Wigfield, et al.
Cancer & Metabolism|August 14, 2020
Correction to: Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cellsMasahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
The Journal of Cell Biology|July 14, 2004
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteinsLaura S Harrington, Greg M Findlay, Alex Gray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancerDaniele Generali, Alfredo Berruti, Maria P Brizzi, et al.
Endocrine-Related Cancer|September 7, 2006
Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancerDaniele Generali, Stephen B Fox, Alfredo Berruti, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 31, 2013
Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenograftsKrishan Kumar, Simon Wigfield, Harriet E Gee, et al.
Pageof 14